The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington state
- PMID: 16953810
- PMCID: PMC2690254
- DOI: 10.1111/j.1468-0009.2006.00458.x
The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington state
Abstract
Little is currently known about the effect of substance abuse treatment on Medicaid expenses and other health care costs for welfare clients. This study examined the association between substance abuse treatment and reductions in medical care expenditures (primarily Medicaid expenses) for General Assistance (GA) welfare clients in Washington State. The treatment group included 3,235 GA clients who received treatment during 2000 or 2001. The comparison group included 4,863 GA clients who needed substance abuse treatment but did not receive it. Substance abuse treatment was associated with a reduction (p < .01) in medical expenses of approximately 2,500 US dollars annually. This estimated savings equaled the cost of treatment and represented approximately 35 percent of the annual Medicaid expenses incurred by GA clients with substance abuse problems.
Similar articles
-
Mental health expenditures for services for people with severe mental illnesses.Psychiatr Serv. 1997 Apr;48(4):485-90. doi: 10.1176/ps.48.4.485. Psychiatr Serv. 1997. PMID: 9090731
-
Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.Soc Sci Med. 2002 Dec;55(12):2267-82. doi: 10.1016/s0277-9536(02)00060-6. Soc Sci Med. 2002. PMID: 12409139
-
Savings from a Medicaid carve-out for mental health and substance abuse services in Massachusetts.Psychiatr Serv. 1997 Sep;48(9):1147-52. doi: 10.1176/ps.48.9.1147. Psychiatr Serv. 1997. PMID: 9285974
-
Medicaid expenditures on behavioral health care.Psychiatr Serv. 2003 Feb;54(2):188-94. doi: 10.1176/appi.ps.54.2.188. Psychiatr Serv. 2003. PMID: 12556599 Review.
-
Medicaid expenditures and state responses.Health Care Financ Rev. 1995 Spring;16(3):1-10. Health Care Financ Rev. 1995. PMID: 10142571 Free PMC article. Review.
Cited by
-
Cross-system data linkage for treatment outcome evaluation: lessons learned from the California Treatment Outcome Project.Eval Program Plann. 2008 May;31(2):125-35. doi: 10.1016/j.evalprogplan.2008.02.003. Epub 2008 Feb 19. Eval Program Plann. 2008. PMID: 18374980 Free PMC article.
-
Using administrative data for longitudinal substance abuse research.J Behav Health Serv Res. 2010 Apr;37(2):252-71. doi: 10.1007/s11414-008-9125-3. Epub 2008 Aug 5. J Behav Health Serv Res. 2010. PMID: 18679805 Free PMC article. Review.
-
Which elements of improvement collaboratives are most effective? A cluster-randomized trial.Addiction. 2013 Jun;108(6):1145-57. doi: 10.1111/add.12117. Epub 2013 Mar 1. Addiction. 2013. PMID: 23316787 Free PMC article. Clinical Trial.
-
Association Between State Medicaid Eligibility Thresholds and Deaths Due to Substance Use Disorders.JAMA Netw Open. 2019 Apr 5;2(4):e193056. doi: 10.1001/jamanetworkopen.2019.3056. JAMA Netw Open. 2019. PMID: 31026034 Free PMC article.
-
Association between supportive interventions and healthcare utilization and outcomes in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a systematic review and meta-analysis.BMC Emerg Med. 2021 Jan 29;21(1):17. doi: 10.1186/s12873-020-00398-9. BMC Emerg Med. 2021. PMID: 33514325 Free PMC article.
References
-
- Boyd DJ. The Bursting State Fiscal Bubble and State Medicaid Budgets. Health Affairs. 2003;22(1):46–61. - PubMed
-
- Cartwright WS. Cost-Benefit Analysis of Drug Treatment Services: Review of the Literature. Journal of Mental Health Policy and Economics. 2000;3:11–26. - PubMed
-
- Diehr P, Yanez D, Ash A, Hornbrook M, Lin D. Methods for Analyzing Health Care Utilization and Costs. Annual Review of Public Health. 1999;20:125–44. - PubMed
-
- Duan N. Smearing Estimate: A Nonparametric Retransformation Method. Journal of American Statistical Association. 1983;78:605–10.
-
- Ellis R, Ash A. Refinements to the Diagnostic Cost Group (DCG) Model. Inquiry. 1996;32(4):418–29. - PubMed